Genome‐Wide <scp>DNA</scp> Methylation Identifies Potential Disease‐Specific Biomarkers and Pathophysiologic Mechanisms in Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Celiac Disease
Blood-based DNA methylation biomarkers can potentially distinguish chronic GI disorders that present with similar symptoms. GO suggested functional significance of the classifiers in disease-specific pathology.
Authors
- Mary Farid (ORCID: https://orcid.org/0000-0003-2251-4443)
- Elizza E. Villarruel (ORCID: https://orcid.org/0000-0003-1328-9109)
- M. B. Thompson
- Tina Storage
- James D. Lewis (ORCID: https://orcid.org/0000-0003-3107-3862)
- Lin Chang (ORCID: https://orcid.org/0000-0001-6800-2967)
- Hamed Nayeb‐Hashemi
- Berkeley N. Limketkai (ORCID: https://orcid.org/0000-0003-2714-6934)
- Jenny Sauk (ORCID: https://orcid.org/0000-0001-6731-8193)
- Swapna Mahurkar‐Joshi (ORCID: https://orcid.org/0000-0001-9591-4590)
- Guy A. Weiss (ORCID: https://orcid.org/0000-0003-2036-6256)
- Lisa Lin
- E. A. Mayer
Institutions
- University of California, Los Angeles (US)
- UCLA Health (US)
- Center for Neurologic Study (US)
- Centre for Genomic Regulation (ES)
- University of Pennsylvania (US)
Publication Details
- Journal
- Neurogastroenterology & Motility
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1111/nmo.14980
- Citations
- 4
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 2.29
Funders
- Crohn's and Colitis Foundation
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases